Alice Yoosun Ho | Duke Department of Radiation Oncology

Medical Professor of Radiation Oncology

Member of the Duke Cancer Institute

Department of Radiation Oncology, Durham, NC 27710
DUMC Box 3085, Durham, NC 27710

alice.ho@duke.edu

Education

M.B.A. 2002 - Tufts University School of Medicine
M.D. 2002 - Tufts University School of Medicine

Grants

Defining Optimal Radiotherapy Dose and Fractionation in Combination with Preoperative Immuno-Chemotherapy in Early-Stage Triple Negative Breast Cancer awarded by National Institutes of Health 2023

Publications

Khan AJ, Marine CB, Flynn J, Tyagi N, Zhang Z, Thor M, et al. A Phase II Study Evaluating the Effect of Intensity Modulated Postmastectomy Radiation Therapy on Implant Failure Rates in Breast Cancer Patients With Immediate, 2-Stage Implant Reconstruction With an MRI Imaging Correlative Substudy. Int J Radiat Oncol Biol Phys. 2024 Apr 2.

Shiao SL, Gouin KH, Ing N, Ho A, Basho R, Shah A, et al. Single-cell and spatial profiling identify three response trajectories to pembrolizumab and radiation therapy in triple negative breast cancer. Cancer Cell. 2024 Jan 8;42(1):70-84.e8.

Hahn EA, Pugh SL, Lu HL, Vela AM, Gillespie EF, Nichols EM, et al. Validation of Patient-Reported Outcomes in Patients With Nonmetastatic Breast Cancer Receiving Comprehensive Nodal Irradiation in the RadComp Trial. International Journal of Radiation Oncology Biology Physics. 2024 Jan 1.

Cho M-G, Kumar RJ, Lin C-C, Boyer JA, Shahir JA, Fagan-Solis K, et al. MRE11 liberates cGAS from nucleosome sequestration during tumorigenesis. Nature. 2024 Jan;625(7995):585–92.

Deutsch A, Lacouture M, Andriessen A, Choi JN, Ho AY, McLellan BN, et al. INDIVIDUAL ARTICLE: USCOM Algorithm for the Prevention and Management of Cutaneous Immunotherapy-Related Adverse Events. J Drugs Dermatol. 2023 Nov 1;22(11):SF389716s3-SF389716s10.

Karukonda P, Ho AY, McDuff S. Pre-operative Radiation and Immunotherapy in the Treatment of Non-metastatic Breast Cancer. Current Breast Cancer Reports. 2023 Sep 1;15(3):213–21.

Oladeru OT, Dunn SA, Li J, Coles CE, Yamauchi C, Chang JS, et al. Looking Back: International Practice Patterns in Breast Radiation Oncology From a Case-Based Survey Across 54 Countries During the First Surge of the COVID-19 Pandemic. JCO Glob Oncol. 2023 Jul;9:e2300010.

Ho AY, Bellon JR. Overcoming Resistance - Omission of Radiotherapy for Low-Risk Breast Cancer. N Engl J Med. 2023 Feb 16;388(7):652–3.

Moran MS, Ho AY. Radiation Therapy for Low-Risk Breast Cancer: Whole, Partial, or None? J Clin Oncol. 2022 Dec 20;40(36):4166–72.

Leventhal J, Lacouture M, Andriessen A, McLellan B, Ho A. United States Cutaneous Oncodermatology Management (USCOM) II: A Multidisciplinary-Guided Algorithm for the Prevention and Management of Acute Radiation Dermatitis in Cancer Patients. J Drugs Dermatol. 2022 Nov 1;21(11):SF3585693–35856914.

Nakhlis F, Portnow L, Gombos E, Daylan AEC, Leone JP, Kantor O, et al. In brief. Curr Probl Surg. 2022 Sep 1;59(9).

Nakhlis F, Portnow L, Gombos E, Daylan AEC, Leone JP, Kantor O, et al. Multidisciplinary considerations in the management of breast cancer patients receiving neoadjuvant chemotherapy. Curr Probl Surg. 2022 Sep;59(9):101191.

Santa-Maria CA, Dunn SA, Ho AY. Immunotherapy Combined with Radiation Therapy in Breast Cancer: A Rapidly Evolving Landscape. Semin Radiat Oncol. 2022 Jul;32(3):291–7.

Mutter RW, Choi JI, Jimenez RB, Kirova YM, Fagundes M, Haffty BG, et al. In Reply to Struikmans et al. Int J Radiat Oncol Biol Phys. 2022 Apr 1;112(5):1289–90.

Naoum GE, Ho AY, Shui A, Salama L, Goldberg S, Arafat W, et al. Risk of Developing Breast Reconstruction Complications: A Machine-Learning Nomogram for Individualized Risk Estimation with and without Postmastectomy Radiation Therapy. Plast Reconstr Surg. 2022 Jan 1;149(1):1e-12e.

Kaidar-Person O, Ho A. Postmastectomy Irradiation in the Setting of Implant-Based Breast Reconstruction. Breast Cancer Radiation Therapy: A Practical Guide for Technical Applications. 2022. p. 247–56.

Ho AY, Tabrizi S, Dunn SA, McArthur HL. Current advances in immune checkpoint inhibitor combinations with radiation therapy or cryotherapy for breast cancer. Breast Cancer Res Treat. 2022 Jan;191(2):229–41.

Naoum GE, Ioakeim MI, Shui AM, Salama L, Colwell A, Ho AY, et al. Radiation Modality (Proton/Photon), Timing, and Complication Rates in Patients With Breast Cancer Receiving 2-Stages Expander/Implant Reconstruction. Pract Radiat Oncol. 2022;12(6):475–86.

Kaidar-Person O, Dahn HM, Nichol AM, Boersma LJ, de Ruysscher D, Meattini I, et al. A Delphi study and International Consensus Recommendations: The use of bolus in the setting of postmastectomy radiation therapy for early breast cancer. Radiother Oncol. 2021 Nov;164:115–21.

Lacouture ME, Choi J, Ho A, Leventhal J, McLellan BN, Andriessen A, et al. US Cutaneous Oncodermatology Management (USCOM): A Practical Algorithm. J Drugs Dermatol. 2021 Sep 1;20(9):3ss-s19.

McDuff SGR, Bellon JR, Shannon KM, Gadd MA, Dunn S, Rosenstein BS, et al. ATM Variants in Breast Cancer: Implications for Breast Radiation Therapy Treatment Recommendations. Int J Radiat Oncol Biol Phys. 2021 Aug 1;110(5):1373–82.

Dahn HM, Boersma LJ, de Ruysscher D, Meattini I, Offersen BV, Pignol J-P, et al. The use of bolus in postmastectomy radiation therapy for breast cancer: A systematic review. Crit Rev Oncol Hematol. 2021 Jul;163:103391.

Marta GN, Ramiah D, Kaidar-Person O, Kirby A, Coles C, Jagsi R, et al. The Financial Impact on Reimbursement of Moderately Hypofractionated Postoperative Radiation Therapy for Breast Cancer: An International Consortium Report. Clin Oncol (R Coll Radiol). 2021 May;33(5):322–30.

Oladeru OT, Dunn SA, Vanbenthuysen LT, Depauw N, Ho AY. New Frontiers in Hypofractionation for Regional Nodal Irradiation in Breast Cancer. Current Breast Cancer Reports. 2020 Dec 1;12(4):285–95.

Nehmeh SA, Fox JJ, Schwartz J, Ballangrud ÅM, Schöder H, Zhao Y, et al. A pilot study of 13N-ammonia cardiac PET imaging to assess subacute cardiotoxicity following adjuvant intensity-modulated radiotherapy for locally advanced breast cancer. Clin Imaging. 2020 Dec;68:283–90.

Naoum GE, Roberts S, Brunelle CL, Shui AM, Salama L, Daniell K, et al. Quantifying the Impact of Axillary Surgery and Nodal Irradiation on Breast Cancer-Related Lymphedema and Local Tumor Control: Long-Term Results From a Prospective Screening Trial. J Clin Oncol. 2020 Oct 10;38(29):3430–8.

Ho AY, Wright JL, Blitzblau RC, Mutter RW, Duda DG, Norton L, et al. Optimizing Radiation Therapy to Boost Systemic Immune Responses in Breast Cancer: A Critical Review for Breast Radiation Oncologists. Int J Radiat Oncol Biol Phys. 2020 Sep 1;108(1):227–41.

Naoum GE, Oladeru OT, Niemierko A, Salama L, Winograd J, Colwell A, et al. Optimal breast reconstruction type for patients treated with neoadjuvant chemotherapy, mastectomy followed by radiation therapy. Breast Cancer Res Treat. 2020 Aug;183(1):127–36.

Oladeru OT, Ho AY. The Local Control of Systemic Therapy. Int J Radiat Oncol Biol Phys. 2020 Jun 1;107(2):233–4.

Naoum GE, Salama L, Niemierko A, Vieira BL, Belkacemi Y, Colwell AS, et al. Single Stage Direct-to-Implant Breast Reconstruction Has Lower Complication Rates Than Tissue Expander and Implant and Comparable Rates to Autologous Reconstruction in Patients Receiving Postmastectomy Radiation. Int J Radiat Oncol Biol Phys. 2020 Mar 1;106(3):514–24.

Ho AY, Barker CA, Arnold BB, Powell SN, Hu ZI, Gucalp A, et al. A phase 2 clinical trial assessing the efficacy and safety of pembrolizumab and radiotherapy in patients with metastatic triple-negative breast cancer. Cancer. 2020 Feb 15;126(4):850–60.

Fagan-Solis KD, Simpson DA, Kumar RJ, Martelotto LG, Mose LE, Rashid NU, et al. A P53-Independent DNA Damage Response Suppresses Oncogenic Proliferation and Genome Instability. Cell Rep. 2020 Feb 4;30(5):1385-1399.e7.

Tabrizi S, McDuff S, Ho AY. Combining Radiation Therapy with Immune Checkpoint Blockadein Breast Cancer. Current Breast Cancer Reports. 2019 Dec 1;11(4):203–16.

Jimenez RB, Hickey S, DePauw N, Yeap BY, Batin E, Gadd MA, et al. Phase II Study of Proton Beam Radiation Therapy for Patients With Breast Cancer Requiring Regional Nodal Irradiation. J Clin Oncol. 2019 Oct 20;37(30):2778–85.

Naoum GE, Salama L, Ho A, Horick NK, Oladeru O, Abouegylah M, et al. The Impact of Chest Wall Boost on Reconstruction Complications and Local Control in Patients Treated for Breast Cancer. Int J Radiat Oncol Biol Phys. 2019 Sep 1;105(1):155–64.

Xu AJ, DeSelm CJ, Ho AY, Gillespie EF, Braunstein LZ, Khan AJ, et al. Overall Survival of Breast Cancer Patients With Locoregional Failures Involving Internal Mammary Nodes. Advances in Radiation Oncology. 2019 Jul 1;4(3):447–52.

Ho AY, Ballangrud A, Li G, Gupta GP, McCormick B, Gewanter R, et al. Long-Term Pulmonary Outcomes of a Feasibility Study of Inverse-Planned, Multibeam Intensity Modulated Radiation Therapy in Node-Positive Breast Cancer Patients Receiving Regional Nodal Irradiation. Int J Radiat Oncol Biol Phys. 2019 Apr 1;103(5):1100–8.

Yu AF, Ho AY, Braunstein LZ, Thor ME, Lee Chuy K, Eaton A, et al. Assessment of Early Radiation-Induced Changes in Left Ventricular Function by Myocardial Strain Imaging After Breast Radiation Therapy. J Am Soc Echocardiogr. 2019 Apr;32(4):521–8.

Jimenez RB, Batin E, Giantsoudi D, Hazeltine W, Bertolino K, Ho AY, et al. Tattoo free setup for partial breast irradiation: A feasibility study. J Appl Clin Med Phys. 2019 Apr;20(4):45–50.

Moo TA, Ho A, El-Tamer M. Postmastectomy Radiation. Oncoplastic and Reconstructive Breast Surgery, Second Edition. 2019. p. 215–20.

Cronin PA, Romanoff A, Zabor EC, Stempel M, Eaton A, Smyth LM, et al. Influence of Age on the Clinical Outcome of Breast Cancer for Men and the Development of Second Primary Cancers. Ann Surg Oncol. 2018 Dec;25(13):3858–66.

Ho AY, Olm-Shipman M, Zhang Z, Siu CT, Wilgucki M, Phung A, et al. A Randomized Trial of Mometasone Furoate 0.1% to Reduce High-Grade Acute Radiation Dermatitis in Breast Cancer Patients Receiving Postmastectomy Radiation. Int J Radiat Oncol Biol Phys. 2018 Jun 1;101(2):325–33.

Jagsi R, Griffith KA, Bellon JR, Woodward WA, Horton JK, Ho A, et al. Concurrent Veliparib With Chest Wall and Nodal Radiotherapy in Patients With Inflammatory or Locoregionally Recurrent Breast Cancer: The TBCRC 024 Phase I Multicenter Study. J Clin Oncol. 2018 May 1;36(13):1317–22.

Ohri N, Sittig MP, Tsai CJ, Hwang E-SS, Mittendorf EA, Shi W, et al. Trends and variations in postmastectomy radiation therapy for breast cancer in patients with 1 to 3 positive lymph nodes: A National Cancer Data Base analysis. Cancer. 2018 Feb 1;124(3):482–90.

Horton JK, Jagsi R, Woodward WA, Ho A. Breast Cancer Biology: Clinical Implications for Breast Radiation Therapy. Int J Radiat Oncol Biol Phys. 2018 Jan 1;100(1):23–37.

Laird J, Lok B, Siu C, Cahlon O, Khan AJ, McCormick B, et al. Impact of an In Situ Component on Outcome After In-Breast Tumor Recurrence in Patients Treated with Breast-Conserving Therapy. Ann Surg Oncol. 2018 Jan;25(1):154–63.

Ho AY, Hu ZI, Mehrara BJ, Wilkins EG. Radiotherapy in the setting of breast reconstruction: types, techniques, and timing. Lancet Oncol. 2017 Dec;18(12):e742–53.

Ohri N, Moshier E, Ho A, Green S, Rhome R, Mazumdar M, et al. Postmastectomy Radiation in Breast Cancer Patients With Pathologically Positive Lymph Nodes After Neoadjuvant Chemotherapy: Usage Rates and Survival Trends. Int J Radiat Oncol Biol Phys. 2017 Nov 1;99(3):549–59.

Hu ZI, Ho AY, McArthur HL. Combined Radiation Therapy and Immune Checkpoint Blockade Therapy for Breast Cancer. Int J Radiat Oncol Biol Phys. 2017 Sep 1;99(1):153–64.

Morrow M, Van Zee KJ, Patil S, Petruolo O, Mamtani A, Barrio AV, et al. Axillary Dissection and Nodal Irradiation Can Be Avoided for Most Node-positive Z0011-eligible Breast Cancers: A Prospective Validation Study of 793 Patients. Ann Surg. 2017 Sep;266(3):457–62.

Razdan SN, Cordeiro PG, Albornoz CR, Disa JJ, Panchal HJ, Ho AY, et al. National Breast Reconstruction Utilization in the Setting of Postmastectomy Radiotherapy. J Reconstr Microsurg. 2017 Jun;33(5):312–7.

Hu ZI, McArthur HL, Ho AY. The Abscopal Effect of Radiation Therapy: What Is It and How Can We Use It in Breast Cancer? Current Breast Cancer Reports. 2017 Mar 1;9(1):45–51.

Tyagi N, Sutton E, Hunt M, Zhang J, Oh JH, Apte A, et al. Morphologic Features of Magnetic Resonance Imaging as a Surrogate of Capsular Contracture in Breast Cancer Patients With Implant-based Reconstructions. Int J Radiat Oncol Biol Phys. 2017 Feb 1;97(2):411–9.

Recht A, Comen EA, Fine RE, Fleming GF, Hardenbergh PH, Ho AY, et al. Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update. Ann Surg Oncol. 2017 Jan;24(1):38–51.

Ohri N, Ho A. Radiotherapy following neoadjuvant chemotherapy in locally advanced breast cancer. Personalized Treatment of Breast Cancer. 2016. p. 171–86.

Yang TJ, Morrow M, Modi S, Zhang Z, Krause K, Siu C, et al. The Effect of Molecular Subtype and Residual Disease on Locoregional Recurrence in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy and Postmastectomy Radiation. Ann Surg Oncol. 2015 Dec;22 Suppl 3(Suppl 3):S495–501.

O’Brien JA, Ho A, Wright GP, Stempel M, Patil S, Krause K, et al. Breast-Conserving Surgery in Bilateral Breast Cancer. Ann Surg Oncol. 2015 Oct;22(10):3389–96.

Lanning RM, Morrow M, Riaz N, McArthur HL, Dang C, Moo T-A, et al. The Effect of Adjuvant Trastuzumab on Locoregional Recurrence of Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Treated with Mastectomy. Ann Surg Oncol. 2015 Aug;22(8):2517–25.

Cuaron JJ, Chon B, Tsai H, Goenka A, DeBlois D, Ho A, et al. Early toxicity in patients treated with postoperative proton therapy for locally advanced breast cancer. Int J Radiat Oncol Biol Phys. 2015 Jun 1;92(2):284–91.

Toi M, Winer EP, Benson JR, Inamoto T, Forbes JF, von Minckwitz G, et al. Personalization of loco-regional care for primary breast cancer patients (part 1). Future Oncol. 2015. p. 1297–300.

Toi M, Winer EP, Benson JR, Inamoto T, Forbes JF, von Minckwitz G, et al. Personalization of loco-regional care for primary breast cancer patients (part 2). Future Oncol. 2015. p. 1301–5.

Mehrara BJ, Ho AY. Breast reconstruction. Diseases of the Breast: Fifth Edition. 2014.

Moo T-A, McMillan R, Lee M, Stempel M, Ho A, Patil S, et al. Impact of molecular subtype on locoregional recurrence in mastectomy patients with T1-T2 breast cancer and 1-3 positive lymph nodes. Ann Surg Oncol. 2014 May;21(5):1569–74.

Pilewskie M, Ho A, Orell E, Stempel M, Chen Y, Eaton A, et al. Effect of margin width on local recurrence in triple-negative breast cancer patients treated with breast-conserving therapy. Ann Surg Oncol. 2014 Apr;21(4):1209–14.

Ho A, Ballangrud A, Li G, Krause K, Siu C, Powell SN. Locally advanced breast cancer. Medical Radiology. 2014 Jan 1;67:215–26.

Ho AY, Patel N, Ohri N, Morrow M, Mehrara BJ, Disa JJ, et al. Bilateral implant reconstruction does not affect the quality of postmastectomy radiation therapy. Med Dosim. 2014;39(1):18–22.

Zumsteg ZS, Morrow M, Arnold B, Zheng J, Zhang Z, Robson M, et al. Breast-conserving therapy achieves locoregional outcomes comparable to mastectomy in women with T1-2N0 triple-negative breast cancer. Ann Surg Oncol. 2013 Oct;20(11):3469–76.

Moo TA, McMillan R, Lee M, Stempel M, Patil S, Ho A, et al. Selection criteria for postmastectomy radiotherapy in t1-t2 tumors with 1 to 3 positive lymph nodes. Ann Surg Oncol. 2013 Oct;20(10):3169–74.

Barry M, Ho A, Morrow M. The evolving role of partial breast irradiation in early-stage breast cancer. Ann Surg Oncol. 2013 Aug;20(8):2534–40.

Perez CA, Zumsteg ZS, Gupta G, Morrow M, Arnold B, Patil SM, et al. Black race as a prognostic factor in triple-negative breast cancer patients treated with breast-conserving therapy: a large, single-institution retrospective analysis. Breast Cancer Res Treat. 2013 Jun;139(2):497–506.

Reyngold M, Wu AJ, McLane A, Zhang Z, Hsu M, Stein NF, et al. Toxicity and outcomes of thoracic re-irradiation using stereotactic body radiation therapy (SBRT). Radiat Oncol. 2013 Apr 25;8:99.

Yang TJ, Ho AY. Radiation therapy in the management of breast cancer. Surg Clin North Am. 2013 Apr;93(2):455–71.

Ho AY, Cody HS. Can the success of ACOSOG Z0011 be extended to Z0011-ineligible patients? Breast Diseases. 2013 Mar 25;24(1):16–9.

Ho AY, Cody HS. Which patients with sentinel node-positive breast cancer can avoid axillary dissection? Am Soc Clin Oncol Educ Book. 2013;61–5.

Milgrom S, Cody H, Tan L, Morrow M, Pesce C, Setton J, et al. Characteristics and outcomes of sentinel node-positive breast cancer patients after total mastectomy without axillary-specific treatment. Ann Surg Oncol. 2012 Nov;19(12):3762–70.

Ho AY, Gupta G, King TA, Perez CA, Patil SM, Rogers KH, et al. Favorable prognosis in patients with T1a/T1bN0 triple-negative breast cancers treated with multimodality therapy. Cancer. 2012 Oct 15;118(20):4944–52.

Ohri N, Cordeiro PG, Keam J, Ballangrud A, Shi W, Zhang Z, et al. Quantifying the impact of immediate reconstruction in postmastectomy radiation: a large, dose-volume histogram-based analysis. Int J Radiat Oncol Biol Phys. 2012 Oct 1;84(2):e153–9.

Wen YH, Ho A, Patil S, Akram M, Catalano J, Eaton A, et al. Id4 protein is highly expressed in triple-negative breast carcinomas: possible implications for BRCA1 downregulation. Breast Cancer Res Treat. 2012 Aug;135(1):93–102.

Ho A, Cordeiro P, Disa J, Mehrara B, Wright J, Van Zee KJ, et al. Long-term outcomes in breast cancer patients undergoing immediate 2-stage expander/implant reconstruction and postmastectomy radiation. Cancer. 2012 May 1;118(9):2552–9.

Kiess AP, McArthur HL, Mahoney K, Patil S, Morris PG, Ho A, et al. Adjuvant trastuzumab reduces locoregional recurrence in women who receive breast-conservation therapy for lymph node-negative, human epidermal growth factor receptor 2-positive breast cancer. Cancer. 2012 Apr 15;118(8):1982–8.

Setton J, Cody H, Tan L, Morrow M, Hudis C, Catalano J, et al. Radiation field design and regional control in sentinel lymph node-positive breast cancer patients with omission of axillary dissection. Cancer. 2012 Apr 15;118(8):1994–2003.

Ho A, Goodman KA. External-beam radiotherapy for liver tumors. Blumgart’s Surgery of the Liver, Biliary Tract and Pancreas. 2012. p. 1370–5.

Edwards-Bennett SM, Jacks LM, McCormick B, Zhang Z, Azu M, Ho A, et al. Patterns of utilization of adjuvant radiotherapy and outcomes in black women after breast conservation at a large multidisciplinary cancer center. Int J Radiat Oncol Biol Phys. 2011 Jul 15;80(4):1102–8.

Karam AK, Hsu M, Patil S, Stempel M, Traina TA, Ho AY, et al. Determinants of outcome in elderly patients with positive sentinel lymph nodes. Am J Surg. 2011 Jun;201(6):734–40.

Ho A, Goenka A, Ishill N, Van Zee K, McLane A, Gonzales AM, et al. The effect of age in the outcome and treatment of older women with ductal carcinoma in situ. Breast. 2011 Feb;20(1):71–7.

Nehmeh SA, Haj-Ali AA, Qing C, Stearns C, Kalaigian H, Kohlmyer S, et al. A novel respiratory tracking system for smart-gated PET acquisition. Medical Physics. 2011 Jan 1;38(1):531–8.

Ho A, Morrow M. The evolution of the locoregional therapy of breast cancer. Oncologist. 2011;16(10):1367–79.

Pugliese M, Stempel M, Patil S, Hsu M, Ho A, Traina T, et al. The clinical impact and outcomes of immunohistochemistry-only metastasis in breast cancer. Am J Surg. 2010 Sep;200(3):368–73.

Burri RJ, Ho AY, Forsythe K, Cesaretti JA, Stone NN, Stock RG. Young men have equivalent biochemical outcomes compared with older men after treatment with brachytherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2010 Aug 1;77(5):1315–21.

Damast S, Ho AY, Montgomery L, Fornier MN, Ishill N, Elkin E, et al. Locoregional outcomes of inflammatory breast cancer patients treated with standard fractionation radiation and daily skin bolus in the taxane era. Int J Radiat Oncol Biol Phys. 2010 Jul 15;77(4):1105–12.

DiMaio CJ, Nagula S, Goodman KA, Ho AY, Markowitz AJ, Schattner MA, et al. EUS-guided fiducial placement for image-guided radiation therapy in GI malignancies by using a 22-gauge needle (with videos). Gastrointest Endosc. 2010 Jun;71(7):1204–10.

Pugliese MS, Karam AK, Hsu M, Stempel MM, Patil SM, Ho AY, et al. Predictors of completion axillary lymph node dissection in patients with immunohistochemical metastases to the sentinel lymph node in breast cancer. Ann Surg Oncol. 2010 Apr;17(4):1063–8.

Goodman K, Wagman R, Ho AY. Cancer of the Liver, Bile Duct, and Gallbladder. Leibel and Phillips Textbook of Radiation Oncology, Third Edition. 2010. p. 820–41.

Ho AY, Burri RJ, Cesaretti JA, Stone NN, Stock RG. Radiation dose predicts for biochemical control in intermediate-risk prostate cancer patients treated with low-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys. 2009 Sep 1;75(1):16–22.

Karam AK, Hsu M, Patil S, Stempel M, Traina TA, Ho AY, et al. Predictors of completion axillary lymph node dissection in patients with positive sentinel lymph nodes. Ann Surg Oncol. 2009 Jul;16(7):1952–8.

Kalinsky K, Ho A, Barker CA, Seidman A. Concurrent use of chemotherapy or novel agents in combination with radiation in breast cancer. Current Breast Cancer Reports. 2009 Mar 1;1(1):29–41.

Wong JS, Ho AY, Kaelin CM, Bishop KL, Silver B, Gelman R, et al. Incidence of major corrective surgery after post-mastectomy breast reconstruction and radiation therapy. Breast J. 2008;14(1):49–54.

Ho AY, Fan G, Atencio DP, Green S, Formenti SC, Haffty BG, et al. Possession of ATM sequence variants as predictor for late normal tissue responses in breast cancer patients treated with radiotherapy. Int J Radiat Oncol Biol Phys. 2007 Nov 1;69(3):677–84.

Ho AY, Burri RJ, Jennings GT, Stone NN, Cesaretti JA, Stock RG. Is seminal vesicle implantation with permanent sources possible? A dose-volume histogram analysis in patients undergoing combined 103Pd implantation and external beam radiation for T3c prostate cancer. Brachytherapy. 2007;6(1):38–43.

Stock RG, Ho A, Cesaretti JA, Stone NN. Changing the patterns of failure for high-risk prostate cancer patients by optimizing local control. Int J Radiat Oncol Biol Phys. 2006 Oct 1;66(2):389–94.

Ho AY, Atencio DP, Peters S, Stock RG, Formenti SC, Cesaretti JA, et al. Genetic predictors of adverse radiotherapy effects: the Gene-PARE project. Int J Radiat Oncol Biol Phys. 2006 Jul 1;65(3):646–55.

Kuo L, Ballangrud ÅM, Ho AY, Mechalakos JG, Li G, Hong L. A VMAT planning technique for locally advanced breast cancer patients with expander or implant reconstructions requiring comprehensive postmastectomy radiation therapy. Med Dosim. 44(2):150–4.

Past Appointments

Adjunct Professor in the Department of Radiation Oncology

Mailing Address

Box 3085 Med Ctr, Durham, NC 27710